首页|酒石酸美托洛尔联合胺碘酮对冠心病合并室性心律失常患者的影响

酒石酸美托洛尔联合胺碘酮对冠心病合并室性心律失常患者的影响

扫码查看
目的:探讨胺碘酮与酒石酸美托洛尔联合疗法在冠心病(CHD)合并室性心律失常患者中的应用价值。方法:选取 2022年 2月—2024年 2月微山县人民医院收治的 86例CHD合并室性心律失常患者为研究对象,依据随机数字表法将其分为对照组和研究组,各 43例。对照组接受胺碘酮治疗,研究组则在对照组基础上增加酒石酸美托洛尔治疗。两组均连续给药治疗 4周,观察两组临床疗效、窦性心律维持情况、心功能、不良反应发生情况。结果:研究组总有效率及窦性心律维持率均较对照组高,差异有统计学意义(P<0。05)。治疗 4周后,研究组左室收缩末容积(47。39±3。56)mL、左室射血分数(53。09±5。06)%、左室舒张末容积(87。78±7。43)mL均高于对照组的(43。77±3。02)mL、(48。76±4。89)%、(80。46±6。78)mL,研究组心率(63。88±6。07)次/min低于对照组的(70。61±7。10)次/min,差异均有统计学意义(P<0。05)。两组不良反应发生率对比,差异无统计学意义(P>0。05)。结论:针对CHD合并室性心律失常的治疗,联合应用酒石酸美托洛尔与胺碘酮的方案疗效显著且确切,能够有效地维持窦性心律,并显著改善患者的心功能状况,且安全可靠。
Effect of Metoprolol Tartrate Combined with Amiodarone on Sinus Rhythm Maintenance and Cardiac Function in Patients with Coronary Heart Disease Complicated by Ventricular Arrhythmia
Objective:To investigate the specific effect of Metoprolol Tartrate combined with Amiodarone in the treatment of coronary heart disease(CHD)with ventricular arrhythmia.Methods:A total of 86 patients with CHD combined with ventricular arrhythmia admitted to Weishan County People's Hospital from February 2022 to February 2024 were selected and randomly divided into a control group and a study group,with 43 patients in each group,according to the random number table method.The control group was treated with amiodarone,while the observation group was treated with metoprolol tartrate in addition to the above.Continuous medication treatment for 4 weeks,observe the clinical efficacy,sinus rhythm maintenance,cardiac function,and adverse reactions of two groups.Results:The total effective rate and sinus rhythm maintenance rate of the study group were higher than those of the control group,the differences were statistically significant(P<0.05).After 4 weeks of treatment,the left ventricular end systolic volume(47.39±3.56)ml,left ventricular ejection fraction(53.09±5.06)%and left ventricular end diastolic volume(87.78±7.43)ml in the study group were all higher than(43.77±3.02)mL,(48.76±4.89)%,and(80.46±6.78)mL in the control group,and the heart rate in the study group was(63.88±6.07)times/min,lower than(70.61±7.10)times/min in the control group,the differences were statistically significant(P<0.05).There was no statistically significant difference in adverse reactions between the two groups(P>0.05).Conclusion:The combination therapy of metoprolol tartrate and amiodarone is effective and precise in the treatment of CHD complicated with ventricular arrhythmia.It can effectively maintain sinus rhythm and significantly improve the patient's cardiac function,which is safe and reliable.

Coronary heart diseaseVentricular arrhythmiaAmiodaroneMetoprololSinus rhythmHeart function

司垒

展开 >

山东省微山县人民医院心内一科,山东 济宁 272000

冠心病 室性心律失常 胺碘酮 酒石酸美托洛尔 窦性心律 心功能

2024

中国伤残医学
中国康复医学会,黑龙江省截瘫研究所

中国伤残医学

影响因子:0.451
ISSN:1673-6567
年,卷(期):2024.32(20)